共 50 条
- [5] Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19 [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
- [9] Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study [J]. The Egyptian Journal of Bronchology, 17